C-Path Establishes Consortium to Spur Pediatric Drug Development

Drug Industry Daily
A A
The Critical Path Institute has formed the Global Pediatric Clinical Trials Network Pre-Launch Consortium to facilitate treatments for infants, children and adolescents — a top FDA priority.

To View This Article:

Login

Subscribe To Drug Industry Daily